Literature DB >> 7450446

Assessment of liver iron content in 271 patients: a reevaluation of direct and indirect methods.

P Brissot, M Bourel, D Herry, J P Verger, M Messner, C Beaumont, F Regnouard, B Ferrand, M Simon.   

Abstract

Two direct methods for hepatic iron assessment (liver iron concentration and stainable liver iron--judged by a new histologic grading) and three indirect methods (serum iron and transferrin saturation, deferoxamine-chelation test, and ferritinemia) were reevaluated in 271 patients. These patients consisted of: 103 with idiopathic hemochromatosis, 39 with alcoholic cirrhosis, 54 with noncirrhotic alcoholic liver diseases, 13 with nonalcoholic liver diseases, and 62 with miscellaneous disorders. The results indicate that: (a) liver iron concentration, well correlated with mobilized excess iron (r = 0.88; p < 0.01), is the method of reference and validates the proposed histologic grading; (b) serum ferritin, which is in good correlation with liver iron concentration (r = 0.80; p < 0.01), is a valuable indirect method for hepatic iron evaluation; (c) regarding the other indirect methods a "boundary zone" may be delimited, thus corresponding to liver iron concentration values of 10.7 mumol/100 mg dry liver weight, beyond which values of serum iron less than 28.6 micrometer or transferrin saturation less than 45% or chelatable iron less than 45 mumol/24 h are rare; and (d) using the various indirect methods, there is a marked risk in idiopathic hemochromatosis to underestimate and in alcoholic liver diseases to overestimate hepatic iron content.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7450446

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  35 in total

1.  Low hepatic iron concentration: evaluation of two complementary methods, colorimetric assay and iron histological scoring.

Authors:  F Imbert-Bismut; F Charlotte; B Turlin; L Khalil; A Piton; P Brissot; Y Le Charpentier; J Delattre; P Opolon; Y Deugnier; T Poynard
Journal:  J Clin Pathol       Date:  1999-06       Impact factor: 3.411

2.  Liver iron concentration and distribution in chronic hepatitis C before and after interferon treatment.

Authors:  E Boucher; A Bourienne; P Adams; B Turlin; P Brissot; Y Deugnier
Journal:  Gut       Date:  1997-07       Impact factor: 23.059

3.  Different forms of iron accumulation in the liver on MRI.

Authors:  İlkay S İdilman; Deniz Akata; Mustafa Nasuh Özmen; Muşturay Karçaaltıncaba
Journal:  Diagn Interv Radiol       Date:  2016 Jan-Feb       Impact factor: 2.630

Review 4.  A diagnostic approach to hemochromatosis.

Authors:  Anthony S Tavill; Paul C Adams
Journal:  Can J Gastroenterol       Date:  2006-08       Impact factor: 3.522

Review 5.  Magnetic resonance imaging measurement of iron overload.

Authors:  John C Wood
Journal:  Curr Opin Hematol       Date:  2007-05       Impact factor: 3.284

Review 6.  Estimating tissue iron burden: current status and future prospects.

Authors:  John C Wood
Journal:  Br J Haematol       Date:  2015-03-12       Impact factor: 6.998

7.  Relation between bone marrow hemosiderin iron, serum iron status markers, and chemical and histochemical liver iron content in 82 patients with alcoholic and nonalcoholic hepatic disease.

Authors:  N Milman; N Graudal; J Hegnhøj; J Visfeldt; P Christoffersen; N S Pedersen
Journal:  Ann Hematol       Date:  1993-04       Impact factor: 3.673

8.  Iron down-regulates leptin by suppressing protein O-GlcNAc modification in adipocytes, resulting in decreased levels of O-glycosylated CREB.

Authors:  Yan Gao; Jingfang Liu; Zhenzhong Bai; Sandy Sink; Chengyu Zhao; Felipe Ramos Lorenzo; Donald A McClain
Journal:  J Biol Chem       Date:  2019-02-01       Impact factor: 5.157

9.  Hyperferritinemia in the Chinese and Asian community: a retrospective review of the University of British Columbia experience.

Authors:  Paul R Yenson; Eric M Yoshida; Charles H Li; Henry V Chung; Peter Wk Tsang
Journal:  Can J Gastroenterol       Date:  2008-01       Impact factor: 3.522

Review 10.  Hemochromatosis. Common genes, uncommon illness?

Authors:  Helen Harrison; Paul C Adams
Journal:  Can Fam Physician       Date:  2002-08       Impact factor: 3.275

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.